FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1348 November 2, 2000 Number 18 Next

Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ito, S.

Drug Therapy for Breast-Feeding Women . On page 120, in Table 1, the management plan and rationale for radioactive compounds should have read, "Breast-feeding should be stopped until the level of radioactivity in milk has returned to the background level," not "for the length of the half-life of the radiolabeled compound used."

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.